FDA warns – Dr. Ergin’s SugarMD Advanced Glucose Support Supplements recalled due to undeclared glyburide, metformin

SugarMDs, LLC, of Maryland Heights, Montana, has voluntarily recalled one lot (Lot 22165-003) of its Advance Glucose Support Supplement in 60-, 120- and 180-count bottles because the product may contain undeclared glyburide and metformin, according to the FDA.

While multiple FDA-approved presription drugs indicated to treat type 2 diabetes include glyburide and metformin as active ingredients, their potential inclusion in this product disqualifies it as a dietary supplement. Any trace of glyburide and metformin in Advanced Glucose Support Supplement renders it a separate, unapproved drug that has not been properly tested for safety and efficacy.

Consumers are advised that glyburide in the product may put them at risk of dangerous, potentially life-threatening drops in blood sugar levels (hypoglycemia). Those suffering from hypoglycemia typically experience “fast heartbeat, shaking, sweating, drowsiness, headache and hunger.” In some cases, hypoglycemia can advance into more severe conditions, including “seizures, coma or death.”

The product’s potential inclusion of metformin as an ingredient puts consumers at a significant risk for a rare but major side effect known as lactic acidosis, an accumulation of lactic acid in the blood which could turn fatal if left untreated. Those suffering from the lactic acidosis typically experience “nausea, vomiting, fatigue, body aches, respiratory distress, abdominal pain, and fast, deep breathing.” It should also be noted that metformin may induce hypoglycemia when consumed with other blood sugar-lowering medications.

Initiated by SugarMDs, LLC on November 8, 2023, the recall covers Advance Glucose Support under Lot 22165-003 and expiration date 09/2024. Affected products were distributed across the U.S. via Amazon and sugarmds.com, in the following packages and corresponding UPC codes (found printed below the “Supplement Facts” panel):

  • 60 count bottle : UPC code 00195893927678
  • 120 count bottle: UPC code 00195893546978
  • 180 count bottle: UPC code 00195893999576

While SugarMDs LLC has not been made aware of any related adverse events to date, the company has since notified its distributing partners and customers via email. A return program for all recalled products has also been established. Consumers, distributors, and retailers who may be in possession of a recalled product are asked to cease all use and return the item(s) to the place of purchase to receive a complete refund.

Recall-related questions may be directed to SugarMDs LLC at 561-462-5053, or via email at feedback@sugarmds.com. Representatives are available Monday through Friday, from 9:00 a.m. to 5:00 p.m. Eastern Time. Anyone experiencing health problems from using the product should seek immediate medical attention.

As the FDA continues to track the recall, consumers are asked to report any adverse reactions or quality issues to the agency’s MedWatch Adverse Event Reporting program.


If you have suffered an adverse health outcome that can be traced to an undeclared ingredient in a medical drug, you deserve compassionate legal support and maximum compensation. Our experienced attorneys at TruLaw are personally invested in protecting consumer safety standards and holding negligent parties responsible. To learn how we can support you in the next steps, connect with us online or try out our free Instant Case Evaluation ℠.